Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. 603707.SS Stock
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Price Chart
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. 603707.SS Financial and Trading Overview
Contents
- Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Price Chart
- Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. 603707.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
- Q&A For Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Stock
| Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. stock price | 12.85 CNY |
| Previous Close | 12.56 CNY |
| Open | 12.56 CNY |
| Bid | 12.43 CNY x 0 |
| Ask | 12.44 CNY x 0 |
| Day's Range | 12.4 - 12.72 CNY |
| 52 Week Range | 12.03 - 23.78 CNY |
| Volume | 9.93M CNY |
| Avg. Volume | 5.97M CNY |
| Market Cap | 20.12B CNY |
| Beta (5Y Monthly) | 0.350684 |
| PE Ratio (TTM) | 18.294117 |
| EPS (TTM) | 0.63 CNY |
| Forward Dividend & Yield | 0.15 (1.23%) |
| Ex-Dividend Date | July 11, 2022 |
| 1y Target Est | 23.3 CNY |
603707.SS Valuation Measures
| Enterprise Value | 21.43B CNY |
| Trailing P/E | 18.294117 |
| Forward P/E | 12.07767 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.2336683 |
| Price/Book (mrq) | 3.0275004 |
| Enterprise Value/Revenue | 5.574 |
| Enterprise Value/EBITDA | 17.887 |
Trading Information
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | 0.350684 |
| 52-Week Change | -46.57% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 23.78 CNY |
| 52 Week Low | 12.03 CNY |
| 50-Day Moving Average | 14.4 CNY |
| 200-Day Moving Average | 16.7 CNY |
603707.SS Share Statistics
| Avg. Volume (3 month) | 5.97M CNY |
| Avg. Daily Volume (10-Days) | 7.08M CNY |
| Shares Outstanding | 1.62B |
| Float | 428.95M |
| Short Ratio | N/A |
| % Held by Insiders | 72.65% |
| % Held by Institutions | 10.72% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.115 |
| Trailing Annual Dividend Yield | 0.91% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.22729999 |
| Last Split Factor | 1.3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 28.43% |
| Operating Margin (ttm) | 27.23% |
| Gross Margin | 52.10% |
| EBITDA Margin | 31.16% |
Management Effectiveness
| Return on Assets (ttm) | 6.70% |
| Return on Equity (ttm) | 17.80% |
Income Statement
| Revenue (ttm) | 3.84B CNY |
| Revenue Per Share (ttm) | 2.36 CNY |
| Quarterly Revenue Growth (yoy) | 11.09% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1.2B CNY |
| Net Income Avi to Common (ttm) | 1.09B CNY |
| Diluted EPS (ttm) | 0.68 |
| Quarterly Earnings Growth (yoy) | 0.70% |
Balance Sheet
| Total Cash (mrq) | 1.81B CNY |
| Total Cash Per Share (mrq) | 1.14 CNY |
| Total Debt (mrq) | 3.36B CNY |
| Total Debt/Equity (mrq) | 51.73 CNY |
| Current Ratio (mrq) | 2.904 |
| Book Value Per Share (mrq) | 4.109 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 465.88M CNY |
| Levered Free Cash Flow (ttm) | -531061696 CNY |
Profile of Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
| Country | China |
| State | N/A |
| City | Nanjing |
| Address | 1/16 Nanjing Jiangbei New |
| ZIP | 210061 |
| Phone | 86 25 8699 0700 |
| Website | https://www.nkf-pharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1396 |
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.
Q&A For Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Stock
What is a current 603707.SS stock price?
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. 603707.SS stock price today per share is 12.85 CNY.
How to purchase Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. stock?
You can buy 603707.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.?
The stock symbol or ticker of Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. is 603707.SS.
Which industry does the Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. company belong to?
The Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. have in circulation?
The max supply of Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. shares is 1.62B.
What is Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. PE Ratio is 20.39682600 now.
What was Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. EPS is 0.63 CNY over the trailing 12 months.
Which sector does the Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. company belong to?
The Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. sector is Healthcare.